Lv3
230 积分 2024-12-10 加入
Mazdutide 9 mg in Chinese adults with a body mass index ≥30 kg/m2 but without diabetes: A phase 2 randomized controlled trial
6天前
已完结
A High-Potency Protein That Normalizes Body Weight in DIO Mice through Triple Agonism at FGF21, GLP1, and GIP Receptors
13天前
已完结
Can weight-loss pills replace injectables? What the science says
14天前
已关闭
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
20天前
已完结
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
20天前
已完结
The story of amylin: from physiology to therapy
25天前
已完结
The apelin/APJ system as a therapeutic target in metabolic diseases
27天前
已完结
The therapeutic potentials of apelin in obesity-associated diseases
27天前
已完结
An in vivo model of Amyloid-Related Imaging Abnormalities (ARIA) predicts ARIA incidence of anti-Aβ antibodies seen in clinical trials
1个月前
已完结
GPCR drug discovery: new agents, targets and indications
1个月前
已完结
皖公网安备34019202002308
